Rezvan F, Khabazkhoob M, Hooshmand E, Yekta A, Saatchi M, Hashemi H (2018) Prevalence and risk factors of pterygium: a systematic review and meta-analysis. Surv Ophthalmol 63(5):719–735. https://doi.org/10.18240/ijo.2018.05.13

Article  PubMed  Google Scholar 

Shibuya M (2011) Vascular endothelial growth factor (VEGF) and Its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer 2(12):1097–1105. https://doi.org/10.1177/1947601911423031

Article  PubMed  PubMed Central  Google Scholar 

Karaman S, Leppänen V-M, Alitalo K (2018) Vascular endothelial growth factor signaling in development and disease. Development 145(14):151019. https://doi.org/10.1242/dev.151019

Article  Google Scholar 

Cardenas-Cantu E, Zavala J, Valenzuela J, Valdez-Garcia JE (2016) Molecular basis of pterygium development. Semin Ophthalmol 31(6):567–583. https://doi.org/10.3109/08820538.2014.971822

Article  PubMed  Google Scholar 

Norrby K (1998) Microvascular density in terms of number and length of microvessel segments per unit tissue volume in mammalian angiogenesis. Microvasc Res 55(1):43–53. https://doi.org/10.1006/mvre.1997.2054

Article  PubMed  Google Scholar 

Rossino MG, Lulli M, Amato R, Cammalleri M, Monte MD, Casini G (2020) Oxidative stress induces a VEGF autocrine loop in the retina: relevance for diabetic retinopathy. Cells 9(6):1452. https://doi.org/10.3390/cells9061452

Article  PubMed  PubMed Central  Google Scholar 

Tan DT, Chee SP, Dear KB, Lim AS (1997) Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol 115(10):1235–1240. https://doi.org/10.1001/archopht.1997.01100160405001

Article  PubMed  Google Scholar 

Hacioglu D, Erdol H (2017) Developments and current approaches in the treatment of pterygium. Int Ophthalmol 37(4):1073–1081. https://doi.org/10.1007/s10792-016-0358-5

Article  PubMed  Google Scholar 

Nuzzi R, Tridico F (2018) How to minimize pterygium recurrence rates: clinical perspectives. Clin Ophthalmol 12:2347–2362. https://doi.org/10.2147/OPTH.S186543

Article  PubMed  PubMed Central  Google Scholar 

Fonseca EC, Rocha EM, Arruda GV (2018) Comparison among adjuvant treatments for primary pterygium: a network meta-analysis. Br J Ophthalmol 102(6):748–756. https://doi.org/10.1136/bjophthalmol-2017-310288

Article  PubMed  Google Scholar 

Zhang Q, Bao N, Liang K, Tao L (2018) Adjuvant use of cyclosporine a in the treatment of primary pterygium: a systematic review and meta-analysis. Cornea 37(8):1000–1007. https://doi.org/10.1097/ICO.0000000000001542

Article  PubMed  Google Scholar 

Ismaeel OMS, Jaafar H, Ibrahim M (2010) Detection of 8 -hydroxydeoxyguanosine enzyme in recurrent pterygium raising a question on its role on recurrence. Int J Ophthalmol 3(2):245–248

PubMed  PubMed Central  Google Scholar 

Kormanovski A, Parra F, Jarillo-Luna A, Lara-Padilla E, Pacheco-Yepez J, Campos-Rodriguez R (2014) Oxidant/antioxidant state in tissue of prymary and recurrent pterygium. BMC Ophthalmol 14:149. https://doi.org/10.1186/1471-2415-14-149

Article  PubMed  PubMed Central  Google Scholar 

Perra MT, Maxia C, Corbu A, Minerba L, Demurtas P, Colombari R et al (2006) Oxidative stress in pterygium: relationship between p53 and 8-hydroxydeoxyguanosine. Mol Vis 12:1136–1142

PubMed  Google Scholar 

Ismaeel OM, Jaafar H, Ibrahim M (2010) Detection of 8-hydroxydeoxyguanosine enzyme in recurrent pterygium raising a question on its role on recurrence. Int J Ophthalmol 3(3):245–248. https://doi.org/10.3980/j.issn.2222-3959.2010.03.15

Article  PubMed  PubMed Central  Google Scholar 

Sun Y, Zhang B, Jia X, Ling S, Deng J (2018) Efficacy and safety of bevacizumab in the treatment of pterygium: an updated meta-analysis of randomized controlled trials. J Ophthalmol. https://doi.org/10.1155/2018/4598173

Article  PubMed  PubMed Central  Google Scholar 

Mohamed TA, Soliman W, Fathalla AM, Refaie EA (2018) Effect of single subconjunctival injection of bevacizumab on primary pterygium: clinical, histopathological and immunohistochemical study. Int J Ophthalmol 11(5):797–801. https://doi.org/10.18240/ijo.2018.05.13

Article  PubMed  PubMed Central  Google Scholar 

Yang HK, Lee YJ, Hyon JY, Kim KG, Han SB (2020) Efficacy of bevacizumab injection after pterygium excision and limbal conjunctival autograft with limbal fixation suture. Graefes Arch Clin Exp Ophthalmol 258(7):1451–1457. https://doi.org/10.1007/s00417-020-04704-w

Article  PubMed  Google Scholar 

Mak RK, Chan TCY, Marcet MM, Choy BNK, Shum JWH, Shih KC et al (2017) Use of anti-vascular endothelial growth factor in the management of pterygium. Acta Ophthalmol (Copenh) 95(1):20–27. https://doi.org/10.1111/aos.13178

Article  Google Scholar 

Johnston SC, Williams PB, Sheppard JD Jr (2004) A comprehensive system for pterygium classification. Invest Ophthalmol Vis Sci 45(13):2940

Google Scholar 

Yang J, Li M, Kamei N, Alev C, Kwan S-M, Kawamoto A et al (2011) CD34+ cells represent highly functional endothelial progenitor cells in murine bone marrow. PLoS ONE 6(5):e20219. https://doi.org/10.1371/journal.pone.0020219

Article  PubMed  PubMed Central  Google Scholar 

de la Puente P, Muz B, Azab F, Azab AK (2013) Cell trafficking of endothelial progenitor cells in tumor progression. Clin Cancer Res 19(13):3360–3368. https://doi.org/10.1158/1078-0432.CCR-13-0462

Article  PubMed  Google Scholar 

Celebi AR, Ozbey C, Mirza GE (2014) The role of mast cells in vascularized recurrent pterygium. Arq Bras Oftalmol 77(5):285–287. https://doi.org/10.5935/0004-2749.20140072

Article  PubMed  Google Scholar 

Weidner N, Semple JP, Welgh WR, Folkman J (1991) Tumour angiogenesis and metastasis- correlation in invasive breast carcinoma. N Engl J Med 324:1–8. https://doi.org/10.1056/NEJM199101033240101

Article  PubMed  Google Scholar 

Tsai Y-Y, Cheng Y-W, Lee H, Tsai F-J, Tseng S-H, Lin C-L et al (2004) Oxidative DNA damage in pterygium. Mol Vis 11:71–75

Google Scholar 

Prabhasawat P, Barton K, Burkett G, Tseng SCG (1997) Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology 104(6):974–985

Article  PubMed  Google Scholar 

Chew FLM, Salowi MA, Mustari Z, Husni MA, Hussein E, Adnan TH et al (2018) Estimates of visual impairment and its causes from the national eye survey in Malaysia (NESII). PLoS ONE 13(6):e0198799. https://doi.org/10.1371/journal.pone.0198799

Article  PubMed  PubMed Central  Google Scholar 

Kocamis O, Bilgec M (2014) Evaluation of the recurrence rate for pterygium treated with conjunctival autograft. Graefes Arch Clin Exp Ophthalmol 252(5):817–820. https://doi.org/10.1007/s00417-014-2581-y

Article  PubMed  Google Scholar 

Maiti R, Mukherjee S, Hota D (2017) Recurrence rate and graft stability with fibrin glue compared with suture and autologous blood coagulum for conjunctival autograft adherence in pterygium surgery: a meta-analysis. Cornea 36(10):1285–1294. https://doi.org/10.1097/ICO.0000000000001270

Article  PubMed  Google Scholar 

Masters JS, Harris DJ (2015) Low recurrence rate of pterygium after excision with conjunctival limbal autograft: a retrospective study with long-term follow-up. Cornea 34(12):1569–1572. https://doi.org/10.1097/ICO.0000000000000597

Article  PubMed  Google Scholar 

Mandour SS, Farahat HG, Mohamed HM (2011) Preoperative subpterygial mitomycin C injection versus limbal conjunctival autograft transplantation for prevention of pterygium recurrence. J Ocul Pharmacol Ther 27(5):481–485. https://doi.org/10.1089/jop.2011.0022

Article  PubMed  Google Scholar 

Ibanez M, Eugarrios MF, Calderon DI (2009) Topical cyclosporin A and mitomycin C injection as adjunctive therapy for prevention of primary pterygium recurrence. Ophthalmic Surg Lasers Imaging 40(3):239–244. https://doi.org/10.3928/15428877-20090430-03

Article  PubMed